Skip to content
Biodatica
Start free

GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC

NISKAYUNA, NY

OncologyGrant-only
Compare Sign in to watch

What changed

NIH R33 · $0.4M · In Vitro Human INtraDuctal (HIND) Model of Early Stage Breast Cancer Progression Heterogeneity

2mo agoNew grantMay 1, 2026Source filing (opens the source filing in a new tab)

Momentum

61no change

Momentum 61 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Grant-only

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

8,833 pre-ticker oncology companies at Grant-only

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    R33 · $396k · non-dilutive

    May 1, 2026

    GEORGIA INSTITUTE OF TECHNOLOGY · PI TAKAYAMA, SHUICHI · NCI · award ends Apr 30, 2029 · In Vitro Human INtraDuctal (HIND) Model of Early Stage Breast Cancer Progression Heterogeneity

    NIH RePORTER · NIH RePORTER 11313243 (opens the source filing in a new tab)

  2. Grant

    R33 · $446k · non-dilutive

    Apr 1, 2025

    GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC · PI DAVIS, BRIAN MICHAEL · NCI · award ends Mar 31, 2028 · A Novel Multi-analyte Approach to Democratize Cancer Biobanking

    NIH RePORTER · NIH RePORTER 11304527 (opens the source filing in a new tab)

  3. Grant

    R01 · $618k · non-dilutive

    Apr 1, 2024

    EMORY UNIVERSITY · PI BADVE, SUNIL S. · NCI · award ends Mar 31, 2029 · Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms

    NIH RePORTER · NIH RePORTER 11299582 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources